Abstract
Background/Objectives:
The purpose of this work was to investigate the association between coffee drinking and diabetes development and potential mediation by oxidative stress and inflammatory biomarkers.
Subjects/Methods:
In 2001–2002, a random sample of 1514 men (18–87 years old) and 1528 women (18–89 years old) were selected to participate in the ATTICA study (Athens metropolitan area, Greece). A validated food-frequency questionnaire was used to assess coffee drinking (abstention, casual, habitual) and other lifestyle and dietary factors. Evaluation of oxidative stress and inflammatory markers was also performed. During 2011–2012, the 10-year follow-up of the ATTICA study was carried out. The outcome of interest in this work was incidence of type 2 diabetes, defined according to American Diabetes Association criteria.
Results:
During follow-up, 191 incident cases of diabetes were documented (incidence 13.4% in men and 12.4% in women). After various adjustments, individuals who consumed ⩾250 ml of coffee (≈1.5cup) had 54% lower odds of developing diabetes (95% confidence interval: 0.24, 0.90), as compared with abstainers. A dose-response linear trend between coffee drinking and diabetes incidence was also observed (P for trend=0.017). When controlling for several oxidative stress and inflammatory biomarkers, the inverse association between habitual coffee drinking and diabetes was found to be mediated by serum amyloid-A levels.
Conclusions:
This work highlights the significance of long-term habitual coffee drinking against diabetes onset. The anti-inflammatory effect of several coffee components may be responsible for this protection.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
International Diabetes FederationIDF Diabetes Atlas, 6th edn. Brussels 2013.
Mursu J, Virtanen JK, Tuomainen TP, Nurmi T, Voutilainen S . Intake of fruit, berries, and vegetables and risk of type 2 diabetes in Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2014; 99: 328–333.
Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C . The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: the CARDIO2000 case-control study. J Nutr 2003; 133: 3228–3232.
Vlachopoulos C, Panagiotakos D, Ioakeimidis N, Dima I, Stefanadis C . Chronic coffee consumption has a detrimental effect on aortic stiffness and wave reflections. Am J Clin Nutr 2005; 81: 1307–1312.
van Dam RM, Feskens EJ . Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2002; 360: 1477–1478.
Boggs DA, Rosenberg L, Ruiz-Narvaez EA, Palmer JR . Coffee, tea, and alcohol intake in relation to risk of type 2 diabetes in African American women. Am J Clin Nutr 2010; 92: 960–966.
Saremi A, Tulloch-Reid M, Knowler WC . Coffee consumption and the incidence of type 2 diabetes. Diabetes Care 2003; 26: 2211–2212.
Reunanen A, Heliovaara M, Aho K . Coffee consumption and risk of type 2 diabetes mellitus. Lancet 2003; 361: 702–703.
van Dam RM, Hu FB . Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 2005; 294: 97–104.
Jiang X, Zhang D, Jiang W . Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 2013; 53: 25–38.
Akash MS, Rehman K, Chen S . Effects of coffee on type 2 diabetes mellitus. Nutrition 2014; 30: 755–763.
Evans JL, Goldfine ID, Maddux BA, Grodsky GM . Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003; 52: 1–8.
Anderson RA, Roussel AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A . Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr 2001; 20: 212–218.
Donath MY, Shoelson SE . Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11: 98–107.
Donath MY, Mandrup-Poulsen T . The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nat Clin Pract Endocrinol Metab 2008; 4: 240–241.
Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C . Coffee drinking influences plasma antioxidant capacity in humans. J Agric Food Chem 2002; 50: 6211–6216.
Kempf K, Herder C, Erlund I, Kolb H, Martin S, Carstensen M et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr 2010; 91: 950–957.
Jacobs S, Kroger J, Floegel A, Boeing H, Drogan D, Pischon T et al. Evaluation of various biomarkers as potential mediators of the association between coffee consumption and incident type 2 diabetes in the EPIC-Potsdam Study. Am J Clin Nutr 2014; 100: 891–900.
Pitsavos C, Panagiotakos DB, Chrysohoou C, Stefanadis C . Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study. BMC Public Health 2003; 3: 32.
Papathanasiou G, Georgoudis G, Papandreou M, Spyropoulos P, Georgakopoulos D, Kalfakakou V et al. Reliability measures of the short International Physical Activity Questionnaire (IPAQ) in Greek young adults. Hellenic J Cardiol 2009; 50: 283–294.
Katsouyanni K, Rimm EB, Gnardellis C, Trichopoulos D, Polychronopoulos E, Trichopoulou A . Reproducibility and relative validity of an extensive semi-quantitative food frequency questionnaire using dietary records and biochemical markers among Greek schoolteachers. Int J Epidemiol 1997; 26 (Suppl 1), S118–S127.
Panagiotakos DB, Pitsavos C, Stefanadis C . Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis 2006; 16: 559–568.
Bunker ML, McWilliams M . Caffeine content of common beverages. J Am Diet Assoc 1979; 74: 28–32.
American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–1197.
Koloverou E, Panagiotakos D, Pitsavos C, Chrysohoou C, Georgousopoulou E, Pitaraki E et al. 10-year incidence of diabetes and associated risk factors in Greece: the ATTICA study (2002-2012). Rev Diabet Stud 2014; 11: 181–189.
Carlsson S, Hammar N, Grill V, Kaprio J . Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol 2004; 33: 616–617.
Kotani K, Tsuzaki K, Sano Y, Maekawa M, Fujiwara S, Hamada T et al. The relationship between usual coffee consumption and serum C-reactive protein level in a Japanese female population. Clin Chem Lab Med 2008; 46: 1434–1437.
Lopez-Garcia E, van Dam RM, Qi L, Hu FB . Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006; 84: 888–893.
Yamashita K, Yatsuya H, Muramatsu T, Toyoshima H, Murohara T, Tamakoshi K . Association of coffee consumption with serum adiponectin, leptin, inflammation and metabolic markers in Japanese workers: a cross-sectional study. Nutr Diabetes 2012; 2: e33.
Pham NM, Wang Z, Morita M, Ohnaka K, Adachi M, Kawate H et al. Combined effects of coffee consumption and serum gamma-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women. Clin Chem Lab Med 2011; 49: 1661–1667.
Marzi C, Huth C, Herder C, Baumert J, Thorand B, Rathmann W et al. Acute-phase serum amyloid A protein and its implication in the development of type 2 diabetes in the KORA S4/F4 study. Diabetes Care 2013; 36: 1321–1326.
Montonen J, Knekt P, Jarvinen R, Reunanen A . Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care 2004; 27: 362–366.
Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J . Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997; 26 (Suppl 1), S59–S70.
Acknowledgements
We thank the ATTICA study group of investigators Yannis Skoumas, Natassa Katinioti, Labros Papadimitriou, Constantina Masoura, Spiros Vellas, Yannis Lentzas, Manolis Kambaxis, Konstadina Palliou, Vassiliki Metaxa, Agathi Ntzouvani, Dimitris Mpougatsas, Nikolaos Skourlis, Christina Papanikolaou, Georgia-Maria Kouli, Aimilia Christou, Adella Zana, Maria Ntertimani, Aikaterini Kalogeropoulou, Evangelia Pitaraki, Alexandros Laskaris, Mihail Hatzigeorgiou and Athanasios Grekas for their assistance in the initial physical examination and follow-up evaluation; Efi Tsetsekou for her assistance in psychological evaluation; as well as the laboratory team Carmen Vassiliadou and George Dedoussis (genetic analysis), Marina Toutouza-Giotsa, Constadina Tselika and Sia Poulopoulou (biochemical analysis) and Maria Toutouza for the database management.
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Koloverou, E., Panagiotakos, D., Pitsavos, C. et al. The evaluation of inflammatory and oxidative stress biomarkers on coffee–diabetes association: results from the 10-year follow-up of the ATTICA Study (2002–2012). Eur J Clin Nutr 69, 1220–1225 (2015). https://doi.org/10.1038/ejcn.2015.98
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2015.98
This article is cited by
-
The Pocket-4-Life project, bioavailability and beneficial properties of the bioactive compounds of espresso coffee and cocoa-based confectionery containing coffee: study protocol for a randomized cross-over trial
Trials (2017)
-
Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis
European Journal of Epidemiology (2016)